SSA
MNTA

Schonfeld Strategic Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-49,351
Closed -$1.64M – 1806
2020
Q2 		$1.64M Buy
49,351
+34,596
+234% +$1.1M 0.04% 463
2020
Q1 		$401K Sell
14,755
-141,089
-91% -$3.93M 0.03% 657
2019
Q4 		$3.08M Buy
+155,844
New +$2.49M 0.08% 275
2019
Q3 		– Sell
-175,900
Closed -$2.19M – 1337
2019
Q2 		$2.19M Buy
175,900
+155,800
+775% +$2.07M 0.08% 273
2019
Q1 		$292K Sell
20,100
-210,246
-91% -$2.69M 0.01% 840
2018
Q4 		$2.54M Buy
+230,346
New +$3.21M 0.1% 273
2018
Q2 		– Sell
-15,197
Closed -$276K – 1063
2018
Q1 		$276K Buy
+15,197
New +$253K 0.02% 614

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Schonfeld Strategic Advisors's MNTA Position: Q3 2020 in Review

Schonfeld Strategic Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 49,351 shares — an estimated $1.64M sold.

Schonfeld Strategic Advisors first reported a position in MNTA in Q1 2018 and held it in 7 quarters. The position peaked at $3.08M in Q4 2019. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Schonfeld Strategic Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 49,351 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.64M.
  • Schonfeld Strategic Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 7 quarters.
  • Schonfeld Strategic Advisors's Momenta Pharmaceuticals, Inc. position peaked at $3.08M in Q4 2019.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.